Gene: SYNJ1
Official Full Name: synaptojanin 1provided by HGNC
Gene Summary: This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07907 | SYNJ1 Knockout cell line (HeLa) | Human | SYNJ1 | 1:3~1:6 | Negative | Online Inquiry |
KO07908 | SYNJ1 Knockout cell line (HCT 116) | Human | SYNJ1 | 1:2~1:4 | Negative | Online Inquiry |
KO07909 | SYNJ1 Knockout cell line (HEK293) | Human | SYNJ1 | 1:3~1:6 | Negative | Online Inquiry |
KO07910 | SYNJ1 Knockout cell line (A549) | Human | SYNJ1 | 1:3~1:4 | Negative | Online Inquiry |
SYNJ1 Gene Knockout Cell Lines represent a cutting-edge tool designed for researchers investigating synaptojanin 1, a key protein involved in clathrin-mediated endocytosis and synaptic function. By precisely deleting the SYNJ1 gene in cultured human or animal cells, these knockout lines enable the detailed study of its role in intracellular trafficking and synaptic transmission, providing insights into various neurological disorders.
The primary function of SYNJ1 is to regulate the recycling of synaptic vesicles, crucial for neurotransmitter release. The knockout of this gene disrupts normal endocytosis, allowing researchers to elucidate the molecular pathways engaged in synaptic plasticity and the effects of its dysfunction in conditions such as Alzheimer's disease, Parkinson’s disease, and other neurodegenerative disorders. This mechanistic understanding is critical for developing targeted therapies.
In terms of scientific importance, SYNJ1 Gene Knockout Cell Lines serve as vital models for exploring the pathophysiology of neurological diseases, as well as for screening potential drug candidates. Researchers can analyze how the absence of SYNJ1 alters cellular responses, aiding the identification of novel intervention points for therapeutic development.
One key advantage of using our SYNJ1 Gene Knockout Cell Lines over traditional methods is their specificity and reliability. Compared to transient knockdown techniques, which can yield variable results, these stable lines ensure consistent gene absence, allowing for reproducible experimental outcomes. Furthermore, our lines have been thoroughly validated, providing researchers with a trusted resource that is easier to manipulate for downstream applications.
By integrating cutting-edge CRISPR/Cas9 technology in their creation, these cell lines position themselves as a robust platform for neuroscience research. For scientists focused on understanding the intricate dynamics of neuronal health, our SYNJ1 Gene Knockout Cell Lines are an invaluable resource that can accelerate discovery and innovation.
At our company, we are committed to advancing research tools that empower scientists in uncovering the complexities of biology. We pride ourselves on our rigorous quality standards and our expertise in biological product development, ensuring that our SYNJ1 Gene Knockout Cell Lines meet the highest expectations for excellence in scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.